1. Home
  2. SLDB vs BWMN Comparison

SLDB vs BWMN Comparison

Compare SLDB & BWMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$7.86

Market Cap

674.4M

Sector

Health Care

ML Signal

HOLD

Logo Bowman Consulting Group Ltd.

BWMN

Bowman Consulting Group Ltd.

HOLD

Current Price

$30.54

Market Cap

572.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLDB
BWMN
Founded
2013
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Military/Government/Technical
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
674.4M
572.9M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
SLDB
BWMN
Price
$7.86
$30.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
4
Target Price
$16.36
$45.50
AVG Volume (30 Days)
1.2M
87.4K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
34.97
329.41
EPS
N/A
N/A
Revenue
$8,094,000.00
$490,017,000.00
Revenue This Year
N/A
$14.93
Revenue Next Year
N/A
$11.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.88
52 Week Low
$3.79
$25.96
52 Week High
$8.87
$45.83

Technical Indicators

Market Signals
Indicator
SLDB
BWMN
Relative Strength Index (RSI) 59.76 43.11
Support Level $5.21 $30.52
Resistance Level $7.94 $30.69
Average True Range (ATR) 0.48 1.19
MACD 0.12 -0.17
Stochastic Oscillator 96.20 23.01

Price Performance

Historical Comparison
SLDB
BWMN

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

About BWMN Bowman Consulting Group Ltd.

Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape and Architecture/Planning.

Share on Social Networks: